NeuroOne Medical Technologies Receivables

The latest receivables for NMTC is $2.4M as of March 2026. That compares with $320M in the prior-year period — down 99.2% year over year. Investors often review this figure alongside NeuroOne Medical Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTC's receivables moved from $320M to $2.4M — a 99.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeuroOne Medical Technologies's operating scale or balance-sheet position.

A receivables figure of $2.4M for NMTC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMTC's receivables ($2.4M), review year-over-year change from $320M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.